High-dose corticosteroid exposure and osteoporosis intervention in adults

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 4, 2006, Pages 497-501

  Che, Maggie ^a   Ettinger, Bruce ^b   Nguyen, Myngoc T ^c   Pressman, Alice R ^b   Johnston, Jennifer ^d  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d Permanente Federation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CALCITONIN; CORTICOSTEROID; ETIDRONIC ACID; FLUNISOLIDE; FLUTICASONE PROPIONATE; RALOXIFENE; RISEDRONIC ACID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ALGORITHM; BONE DENSITOMETRY; BONE DENSITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DATA BASE; DOSE RESPONSE; DRUG MEGADOSE; DRUG USE; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MEDICAL RECORD; OSTEOLYSIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING TEST; TREATMENT OUTCOME;

EID: 33750097185     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60941-6     Document Type: Article

References (21)

1. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983;309:265-268.
2. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998;27: 465-483.
3. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112: 352-364.
4. Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am. 2003;32:135-157.
5. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995;54: 49-52.
6. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int. 2002;13:777-787.
7. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996;313: 344-346.
8. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941-947.
9. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105:1722-1727.
10. Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet. 2000; 355:1399-1403.
11. Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res. 2001; 16:782-787.
12. Kelly HW. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol. 2003;112:469-478; quiz 479.
13. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112(3 suppl):S1-S40.
14. Ettinger B, Chidambaran P, Pressman A. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am J Manag Care. 2001;7:597-605.
15. Ettinger B, Pressman A, Shah HA. Who bears responsibility for glucocorticoid-exposed patients in a large health maintenance organization? J Manag Care Pharm. 2001;7:228-232.
16. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report: guidelines for the diagnosis and management of asthma: update on selected topics 2002 [monograph on the Internet]. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2003 [cited December 1, 2004]. (NIH publication 02-5074) Available at: http://www.nhlbi.nih.gov/ guidelines/asthma/asthmafullrpt.pdf.
17. Jasani MK, Boyle JA, Greig WR, et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med. 1967;36:261-276.
18. Richy F, Bousquet J, Ehrlich GE, et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporosis Int. 2003;14:179-190. Epub 2003 Apr 23.
19. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44: 1496-1503.
20. Mortimer KJ, Harrison TW, Tattersfield AE. Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol. 2005; 94:15-21; quiz 22-3, 79.
21. Kaiser Permanente. Care Management Institute. Evidence based guidelines and technical review for adult asthma in primary care [monograph on the Internet]. Oakland, CA: Kaiser Permanente Medical Program; 2003 [cited December 1, 2004]. Available at: http://cl.kp.org/pkc/national/cmi/programs/asthma/ guideline/files/adult_asthma_guidelines.pdf.